Ownership history in Squarepoint Ops LLC · 23 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in LIGAND PHARMACEUTICALS INC (LGND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 17,897 | +14,403 | +412.2% | 0.00% | $3.2M | $177.14 |
| 2025 Q1 | REDUCED | 3,494 | -13,305 | -79.2% | 0.00% | $367K | $105.14 |
| 2024 Q4 | ADDED | 16,799 | +13,741 | +449.3% | 0.00% | $1.8M | $107.15 |
| 2022 Q4 | REDUCED | 3,058 | -8,775 | -74.2% | 0.00% | $204K | $66.80 |
| 2022 Q3 | ADDED | 11,833 | +3,967 | +50.4% | 0.01% | $1.0M | $53.72 |
| 2022 Q1 | ADDED | 7,866 | +6,559 | +501.8% | 0.00% | $885K | $70.17 |
| 2021 Q4 | REDUCED | 1,307 | -3,074 | -70.2% | 0.00% | $202K | $96.36 |
| 2021 Q3 | REDUCED | 4,381 | -208 | -4.5% | 0.00% | $610K | $86.91 |
| 2021 Q1 | ADDED | 4,589 | +970 | +26.8% | 0.00% | $700K | $95.10 |
| 2020 Q4 | REDUCED | 3,619 | -6,296 | -63.5% | 0.00% | $360K | $62.04 |
As of 2025 Q4 — sorted by position size